- Biopsy can be performed for surveillance or suspected rejection.
- SIR guidelines classify this as a high-risk procedure for bleeding (>1.5% risk of major bleeding).
- Antibiotics: None required.
- Routine labs: CBC, coagulation screen, and type and screen should be performed in all patients. If the biopsy is being performed for surveillance and there is no evidence of active liver disease, then CBC and coagulation tests do not need to be repeated if they were performed within the last 3 months.
- Withhold anticoagulant and antiplatelet medications for 3-5 days.
References:
Sheth RA, Baerlocher MO, Connolly BL, et al. Society of Interventional Radiology Quality Improvement Standards on Percutaneous Needle Biopsy in Adult and Pediatric Patients. J Vasc Interv Radiol. 2020;31(11):1840-1848.
- SIR guidelines classify this as a high-risk procedure for bleeding (>1.5% risk of major bleeding).
- Antibiotics: None required.
- Routine labs: CBC, coagulation screen, and type and screen should be performed in all patients. If the biopsy is being performed for surveillance and there is no evidence of active liver disease, then CBC and coagulation tests do not need to be repeated if they were performed within the last 3 months.
- Withhold anticoagulant and antiplatelet medications for 3-5 days.
References:
Sheth RA, Baerlocher MO, Connolly BL, et al. Society of Interventional Radiology Quality Improvement Standards on Percutaneous Needle Biopsy in Adult and Pediatric Patients. J Vasc Interv Radiol. 2020;31(11):1840-1848.